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Introduction: Posterior urethral valves are the commonest form of 
obstructive uropathy in pediatrics and a common cause of chronic kidney 
disease (CKD) during childhood with estimated renal failure rate of 25-40%. 
This study aims at evaluating long term changes in kidney and bladder 
functions of children with posterior urethral valves after ablation, and 
at assessing predictors of late renal outcome, considering challenges in 
Egypt as a developing country.
Materials and Methods: A retrospective study of 30 surgically managed 
PUVs patients who attended at Alexandria University Children’s Hospital 
for follow up. Patients underwent surgery between 2005 and 2016. Mean 
postoperative follow up period was 6.7±3.8 years (range 3.1 to 14.6 
years). Data collected included age at presentation, clinical presentation, 
serum creatinine (initial, nadir, and last follow up), eGFR at last follow up, 
renal ultrasound (initial, and last follow up), voiding cystourethrogram 
(initial, and last follow up), and urodynamic studies at last follow up.
Results: Thirty patients underwent PUVs ablation at a median age of 9 
months. Ten (33.3%) patients were diagnosed antenatally. At the last 
follow up visit, 14 (46.7%) patients had moderate-severe CKD. Twenty-five 
(83.3%) patients had abnormalities in their urodynamic studies. Univariate 
analysis showed the need for re-ablation, use of anti-cholinergics, high 
initial serum creatinine, high nadir creatinine, presence of VUR, history 
of febrile UTIs and presence of proteinuria were significantly associated 
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Introduction 
Posterior urethral valves (PUVs) are considered 
one of the most common causes of chronic kidney 
disease (CKD) and end-stage renal disease (ESRD) 
in children.1
Urinary outflow obstruction during early 
development caused by PUVs has serious long-
term consequences on the structure and function of 
the developing kidney and bladder.2 Valves ablation 
is the treatment of choice aiming at preservation of 
kidney and bladder functions. 3
We aimed to assess the long-term outcome of 
treating PUVs in children, on bladder and kidney 
functions, and identifying predictive factors of 
long-term renal functions, focusing on potential 
limitations in developing countries.
Materials and Methods
A retrospective study of 30 surgically managed 
with low eGFR. Multivariate analysis showed that high nadir creatinine 
and presence of VUR were independent factors associated with lower 
e-GFR at last follow-up. Antenatal diagnosis was significantly associated 
with better e-GFR.
Conculsion: Nadir creatinine and vesicoureteral reflux have high 
prognostic value for late renal functions, and antenatal diagnosis is 
associated with better renal functions in patients with posterior urethral 
valves.Increasing family awareness, antenatal care facilities,and referal to 
tertiary care centers are priorities for promoting the antenatal diagnosis 
and management in developing countries.Facilities and training for 
prenatal intervention should be encouraged.
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PUVs patients who attended Alexandria University 
Children’s Hospital for follow up visits between 
January 2018 and December 2019 was carried 
out. Patients underwent surgery between 2005-
2016; with a mean postoperative follow up period 
of 6.7±3.8 years (range 3.1 to 14.6 years). Data 
retrieved from patients records included age at 
presentation, clinical presentation, serum creatinine 
(initial, nadir), preoperative renal ultrasound and 
preoperative voiding cystourethrogram. During 
the last follow up visit, serum creatinine, eGFR, 
renal ultrasound, voiding cystourethrogram and 
urodynamic studies of patients were investigated. 
The formula for eGFR was as follows: eGFR (mL/
min/1.73m2) = 0.413×height in centimeter/serum 
creatinine in mg/dL. 4
Urodynamics (UDS) were performed using Solar 
Silver Urodynamics-Medical Measurement 
System (MMS), in the form of free uroflowmetry 
with post-void residual urine (PVR) estimation and 
pressure flow study. Bladder contractility index 
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(BCI) and bladder outlet obstruction index (BOOI) 
were also calculated. 5
The study was approved by the Ethical Committee 
of the Faculty of Medicine. Informed parental 
consent was obtained for every enrolled patient.
Statistical analysis was carried out using IBM 
SPSS version 20.0.
Results
Patients were followed-up after ablation for a mean 
of 6.7±3.8 years (range 3.1 to 14.6 years). Ten 
(33.3%) patients were diagnosed antenatally, none 
of them had prenatal intervention. Twenty (66.7%) 
patients were diagnosed postnatally, with a median 
age at presentation of 3.5 months (range:0 to 33 
months). Median age at valves ablation (either 
primary ablation or after temporary vesicostomy) 
was 9 months (range:7 days to 42 months). 
Obstructive symptoms and urosepsis were the most 
common clinical presentations before ablation. 
Table 1 shows the presenting manifestations of our 
patients.
Table 1: Presenting manifestations of the 30 patients
Presenting manifestations No.   (%)
Antenatal hydronephrosis 10 (33.3)
Obstructive symptoms 17 (56.7)
Urosepsis 16  (53.3)
Febrile UTIs 5  (16.7)
Renal failure 3  (10)
Day-time incontinence 2  (6.7)
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Before ablation, mean serum creatinine was 
1.43±1.07 mg/dL. All patients had hydronephrosis 
(Bilateral in 93%, grade 3 and 4 in 90% of the renal 
units). Vesicoureteral reflux (VUR) was found in 
24 (80%) patients (unilateral in 14 and bilateral in 
10). Most (70.6%) of the refluxing renal units were 
of grades IV and V.
After ablation, 25 (83.3%) patients received bladder 
pharmacotherapy (anticholinergics, alpha-blockers 
or both), while clean intermittent catheterization 
was required in 6 (20%) patients. Nineteen (63.3%) 
patients needed further surgeries, as illustrated in 
Table 2. Twenty-four (80%) patients had febrile 
urinary tract infections (UTIs) during follow-up.
Mean nadir creatinine was 0.61±0.45 mg/dL 
(range: 0.2-1.9 mg/dL). At last follow-up, mean 
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Table 2: Initial and subsequent surgical interventions in the patients
Surgical interventions No. (%)
Primary ablation 22 (73.3)
Vesicostomy then ablation 8 (26.7)




Dilatation of urethral stricture 2 (6.7)
Vesicostomy after ablation 1 (3.3)
Right nephrectomy 1 (3.3)
Bladder neck incision 1 (3.3)
serum creatinine was 1.37±1.5 mg/dL, it was 
within normal range in 13 (43.3%) patients. Serum 
creatinine was not significantly different from this 
value at presentation. 
At last follow up, mean eGFR was 64.4±39.5 mL/
min/1.73m2. In 16 (53.3%) patients, eGFR was>60 
mL/min/1.73m2, while 14 (46.7%) patients 
had moderate to severe CKD (eGFR<60 mL/
min/1.73m2 for≥3 months). One (3.3%) patient was 
on maintenance hemodialysis (ESRD). Twenty-
two (73.4%) patients had proteinuria (nephrotic 
range in 26.7% of the patients).
At last follow-up, hydronephrosis was still present 
in 90% of patients, but there was a significant 
reduction in cases with bilateral hydronephrosis 
(p=0.005) and significant improvement in grade 
of hydronephrosis (p<0.001). There was signifcant 
reduction in the frequency (p = 0.025) and grade of 
VUR (p=0.007).
At last follow up, urodynamic abnormalities were 
detected in 25(83.3%) patients Table 3. 
BOOI showed obstruction in 2(6.7%) patients, due 
to bladder neck hypertrophy as diagnosed through 
cystoscopy after exclusion of residual valves. 
Fifty-seven percent of the patients who were 
above 5 years of age at last follow up had day-time 
incontinance. Incontinence was due to detrusor 
overactivities in 6 (33.3%) patients, overflow in 
6 (33.3%) patients, bladder hypocompliance in 3 
(16.7%) patients, and both detrusor overactivities 
and bladder hypocompliance in 3 (16.7%) of the 
incontinent patients.
On univariate analysis for the predictors of long 
term predictors of renal functions, the need for 
re-ablation, use of anti-cholinergics, high initial 
serum creatinine, high nadir creatinine, presence 
of VUR, history of febrile UTIs and presence of 
proteinuria were significantly associated with 
low eGFR. Multivariate analysis showed that 
high nadir creatinine and presence of VUR were 
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Table 3: Urodynamic findings among the patients at last follow-up (N=30)
UDS parameters Value
Uroflowmetry
Maximum flow rate (mL/s) range (mean±SD) 5–22 (12.72±4.51)
Low no. (%) 8 (26.7)
Post-void residual (mL) range (mean±SD) 0-150 (31±43.26)
Significant no. (%) 11 (36.7)
Pressure-Flow study
Bladder capacitySD range (mean) -2.78 – 1.4 (0)
Small capacity no. (%) 3 (10)
Compliance(mL/cmH2O) range (mean±SD) 3.5–56 (28.16±16.44)
Hypocompliance no. (%) 8 (26.7)
Reduced sensation no. (%) 5 (16.7)
Detrusor overactivities no. (%) 19 (63.3)
Maximum flow rate (mL/s) range (mean±SD) 4–23 (13.58±5.13)
Low no. (%) 8 (26.7)
Post-void residual(mL) range (mean±SD) 0–250 (42.83±64.70)
Significant no. (%) 11 (36.7)
Pdet@Qmax* (cmH2O)range (mean±SD) 8–82 (44.53±19.48)
Bladder contractility index range (mean±SD) 35–182 (111.52±40.49)
Strong contractility > 130 no. (%) 5 (16.7)
Weak contractility <65 no. (%) 8 (26.6)
Bladder outlet obstruction index range (mean±SD) 2-47 (18.58±11.91)
Obstructed (>40) no. (%) 2 (6.7)
Equivocal (20–40) no. (%) 11 (36.7)
           * Pdet@Qmax: Detrusor pressure at maximum flow rate
independent factors associated with lower e-GFR 
at last follow-up. Meanwhile, age at presentation, 
age at ablation, mode of surgical intervention and 
bladder dysfunction had no statistical significant 
impact on long-term renal outcome. Antenatal 
diagnosis was significantly associated with better 
e-GFR.
Discussion
Prenatal diagnosis allows early intervention 
before irreversible renal and bladder pathological 
changes occur. In this study 33.3% of the patients 
were diagnosed antenatally, which is consistent 
with prenatal detection rate ranging between 
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31% - 42.3% in developed countries.6, 7 However, 
antenatal diagnosis was less frequent (3.9%-25%) 
in other series in developing countries. 8-10 Yet, 
none of the prenatally diagnosed cases had a chance 
of prenatal intervention due to limited medical 
infrastructures and limited surgical experience. 
Median age for postnatal diagnosis was 3.5 
months, denoting late diagnosis in many cases. In 
the literature, median age of postnatal diagnosis 
varied from two months7, 9 up to 22 months.11 These 
variations may be due to differences in parents’ 
awareness and availability of health facilities, and 
referral system of such cases to tertiary referral 
centers.
Primary valves ablation was done in 73.3% of 
our patients. valves ablation was also the most 
common initial surgery in many reports.7, 10 In our 
cohort, median age at valves ablation, whether 
initially or after vesicostomy was 9 months; similar 
to that reported by Rianthavorn and Parkpibul. 12 
In contrast, median age of ablation reported by 
Coquillette et al was 13 days, as their study was 
on  neonates. 16
Nineteen (63.3%) cases in our study needed further 
surgical management. Re-ablation was done for 11 
patients (36.7%). Bilgutay et al[7]stated that 42% 
of their patients required more than one operation. 
In other studies, only 10%-15.4% of the patients 
required re-ablation. 7, 8, 13 The higher percentage 
in the current series may be due to loss of follow-
up of many patients with asymptomatic courses 
after ablation, or may be due to limited availability 
of suitable sized neonatal endoscopes leading to 
inefficient primary ablation.
Mean serum creatinine at presentation was 
similar to mean values reported in other studies. 
7, 10, 14 Mean nadir creatinine was in accordance 
with values reported by other authors.7, 13 Nadir 
creatinine was <1mg/dL in 90% of our patients 
and was comparable to the study by Coquillette 
et al15 who reported similar values in 85% of their 
patients. Proteinuria was found in 73.4% of our 
cases. It was reported to be between44.5-55% by 
other authors.16, 17
VUR was found in 80% of patients. In the 
literature, VUR among PUVs patients varied from 
37.7% -81%.8, 9, 11 The higher incidence of VUR 
among our patients may be due to late presentation 
of our patients and higher incidence of bladder 
dysfunction among them. VUR had a high grade 
in 70.6% of the refluxing units; nearly the same 
percentage was reported in other studies. 18, 19
Incontinence was found in 57% of patients, aged 
more than 5 years at last follow-up. Incontinence 
was reported in 7-35% of the cases in other 
studies. 20, 21 Incontinence in our patients was 
due to detrusor overactivities, overflow and 
bladder hypocompliance. In the literature, other 
possible causes include reduced bladder sensation, 
nephrogenic diabetes insipidus or sphincteric 
injury during valves ablation. 22
Bladder function abnormalities were detected in 
83.3% of our patients. Parkhouse et al23 reported 
bladder dysfunction in about 75% of their cases. 
Bladder hypocompliance was found in 26.7% of 
our patients, similar to the finding of Puri et al. 24 
However, other studies reported higher percentages 
of hypocompliance (46-57%).13, 25 This could be 
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due to the frequent use of anticholinergics among 
our patients. Detrusor overactivity was recorded 
in 63.3% of our patients, similar to the percentage 
reported by Sarhan et al.13 In contrast, Ansari et al25 
found detrusor overactivity in 20% of the patients.
Hypocontractile bladder was found in 26.6% of our 
patients and was reported in only 12% by Ansari et 
al, 25 but in 56% of cases in a study by Androulakakis 
et al. 26 Significant PVR was detected in 36.7% 
of our patients, and in 26-56% in other studies. 
26, 27 The disparity in the reported frequencies of 
urodymanic abnormalities in PUV patients may 
be due to selection bias as some studies did UDS 
only for PUV patients who had urinary complaints, 
or due to differences in the defintions of UDS for 
abnormalities such as hypocompliance. 28
At last follow-up, 14 patients (46.7%) had 
moderate to severe CKD and one patient (3.3%) 
was on maintenance hemodialysis (ESRD). In a 
systematic review, CKD was reported in 0–32% 
of PUV patients and ESRD in  0-20% of them. 21 
The discrepancy in the results may be attributed to 
differences in definition of CKD, time of valves 
ablation and quality of medical care.
On univariate analysis, the need for re-ablation, 
use of anti-cholinergics, high intial creatinine, high 
nadir creatinine, presence of VUR, history of febrile 
UTIs and presence of proteinuria were significantly 
associated with low eGFR. Multivariate analysis 
showed that high nadir creatinine and presence 
of VUR were independent factors associated with 
lower e-GFR at last follow-up Table 4. In accord 
with our results, Mcleod et al,[29]found that the 
presence of VUR, high nadir creatinine and use 
of anticholinergics were associated with need for 
renal replacement therapy on univariate analysis, 
while on multivariate analysis, nadir creatinine 
was the only independent factor. Nadir creatinine 
was the only independent predictor of final renal 
function in other studies as well. 7, 13, 30
In our study, the presence of proteinuria was 
significantly associated with lower e-GFR at last 
follow-up in univariate analysis. Proteinuria was 
reported as statistically significant risk factor for 
CKD. 31
Parkhouse et al32 reported significant relation 
between incontinence and CKD or progression to 
ESRD. In our study and in that of Ghanem et al, 
33 no correlation was found between incontinence 
and e-GFR. In harmony with our results, Ghanem 
et al33 and Lopez-Pereira et al34 reported that VUR 
is a common cause of impaired renal function. On 
the contrary, Ezal et al31 found that neither VUR 
nor UTI had significant impact on renal function.
Ghanem et al33 found that hypocompliance and 
detrusor overactivity unfavorably correlated with 
renal function, but this relation was not proved 
in our study. According to Ansari et al,30 BCI and 
hypocompliance were significantly associated 
with poor renal function, whereas BOOI was not. 
In our study, neither BCI nor BOOI had significant 
effect on the e-GFR. 
Antenatal diagnosis was significantly associated 
with better e-GFR at last follow-up on both 
univariate and multivariate analyses. Sarhan et al35 
also reported better long-term outcome in patients 
who were detected prenatally. In contrast, antenatal 
diagnosis did not decrease the rate of renal function 
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Table 4: Univariate and multivariate analyses for the parameters affecting 




r p B (95%C.I) p
Age at diagnosis (months) -0.193 0.334
Antenatal diagnosis 0.490‡ 0.009 ‡ 21.570(1.081 – 42.658) 0.040‡
Primary ablation 0.192 0.338
Vesicostomy then ablation -0.192 0.338
Age at ablation (months) -0.228 0.253
Need for re-ablation -0.411‡ 0.033‡ -27.888(-57.497 - -1.721) 0.063
Anticholinergics -0.421‡ 0.029‡ 9.366 (-19.161 - 37.893) 0.499
Alpha-blockers -0.014 0.943
Creatinine at presentation -0.563‡ 0.002‡ -7.510(-18.424 - 3.404) 0.165
Nadir creatinine* -0.641‡ <0.001‡ -40.641(-66.644 - -14.437) 0.004‡
Presence of VUR at presentation -0.437‡ 0.023‡ -19.407(-37.450 - -1.763) 0.033‡
Febrile UTIs -0.496‡ 0.009‡ -12.097 (-40.309 - 16.116) 0.380
Incontinence at last follow-up -0.125 0.535
Bladder capacity -0.173 0.388
Bladder compliance -0.278 0.160
Post-void residual urine -0.145 0.471
Detrusor overactivities -0.302 0.126
BCI 0.074 0.712
BOOI -0.188 0.347
Proteinuria -0.541‡ 0.004‡ 0.648 (-4.018 – 5.314) 0.774
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r: Correlation coefficient   
B: Unstandardized coefficients      
C.I: Confidence interval 
UTIs: Urinary tract infections
VUR: Vesicoureteral reflux
BCI: Bladder contractility index  
BOOI: Bladder outlet obstruction index
* Nadir creatinine was not available in three 
patients.
†: All variables with p<0.05 were included in 
the multivariate analysis 
‡: Statistically significant at p ≤ 0.05
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decline in the study of Vasconcelos et al. 17
This paper reflected challenges in PUVs 
management in Egypt as a developing country, in 
the form of limited prenatal diagnosis and prenatal 
management. Increasing family awareness, 
antenatal care facilities, and referral to tertiary care 
centers are priorities for promoting the antenatal 
diagnosis and management in developing countries. 
Facilities and training for prenatal intervention 
should be encouraged.
Conculsion
Nadir creatinine and vesicoureteral reflux have 
high prognostic value for late renal function. 
Antenatal diagnosis is associated with better renal 
function in patients with posterior urethral valves.
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